Clinical trial
Effects of Insulin Glargine and Lixisenatide on the Brain
NCT03881995
Study timeline
Study start (actual)2019-03-18Date precision: day
Registry last updated2020-07-10
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus, Type 2unresolved
Interventions
IGlarLixiDRUG
Insulin Glargine 100 UNT/MLDRUG · verified · RxNorm: insulin glargine 100 UNT/ML
Sponsors & collaborators
University Hospital Tuebingenlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03881995 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.